{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T01:21:38Z","timestamp":1773364898010,"version":"3.50.1"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T00:00:00Z","timestamp":1512604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico (CL)","award":["1170718"],"award-info":[{"award-number":["1170718"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0189213","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T13:38:46Z","timestamp":1512653926000},"page":"e0189213","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Docking and quantitative structure\u2013activity relationship of bi-cyclic heteroaromatic pyridazinone and pyrazolone derivatives as phosphodiesterase 3A (PDE3A) inhibitors"],"prefix":"10.1371","volume":"12","author":[{"given":"Camila","family":"Mu\u00f1oz-Guti\u00e9rrez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"C\u00e1ceres-Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Adasme-Carre\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iv\u00e1n","family":"Palomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0182-1444","authenticated-orcid":true,"given":"Julio","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,12,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0955-0674(99)00073-3","article-title":"Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions","volume":"12","author":"SH Soderling","year":"2000","journal-title":"Curr Opin Cell Biol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1152\/physrev.1995.75.4.725","article-title":"Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms","volume":"75","author":"JA Beavo","year":"1995","journal-title":"Physiol Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"13729","DOI":"10.1074\/jbc.274.20.13729","article-title":"Cyclic GMP phosphodiesterase-5: target of sildenafil","volume":"274","author":"JD Corbin","year":"1999","journal-title":"J Biol Chem"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1043-2760(01)00523-9","article-title":"Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling","volume":"13","author":"C Mehats","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"19D","DOI":"10.1016\/S0002-9149(01)01673-3","article-title":"Comparative effects of cilostazol and other therapies for intermittent claudication","volume":"87","author":"DL Dawson","year":"2001","journal-title":"Am J Cardiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4065\/81.1.59","article-title":"Platelets in atherothrombosis","volume":"81","author":"DA Vorchheimer","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"ref7","first-page":"302","article-title":"Regulation of cyclic AMP metabolism in human platelets. Sequential activation of adenylate cyclase and cyclic AMP phosphodiesterase by prostaglandins","volume":"20","author":"R Alvarez","year":"1981","journal-title":"Mol Pharmacol"},{"key":"ref8","first-page":"215","article-title":"Pharmacological manipulation of tissue cyclic AMP by inhibitors. Effects of phosphodiesterase inhibitors on the functions of platelets and vascular endothelial cells","volume":"25","author":"T Tani","year":"1992","journal-title":"Adv Second Messenger Phosphoprotein Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.cellsig.2007.03.012","article-title":"Role of phosphodiesterase type 3A and 3B in regulating platelet and cardiac function using subtype-selective knockout mice","volume":"19","author":"B Sun","year":"2007","journal-title":"Cell Signal"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1210\/edrv-16-3-370","article-title":"Recent progress in understanding the hormonal regulation of phosphodiesterases","volume":"16","author":"M Conti","year":"1995","journal-title":"Endocr Rev"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrd893","article-title":"Phosphodiesterase 5 inhibitors: current status and potential applications","volume":"1","author":"DP Rotella","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1164\/ajrccm.157.2.9708012","article-title":"Phosphodiesterase isozymes: molecular targets for novel antiasthma agents","volume":"157","author":"TJ Torphy","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1021\/bi049868i","article-title":"Crystal structure of human phosphodiesterase 3B: Atomic basis for substrate and inhibitor specificity","volume":"43","author":"G Scapin","year":"2004","journal-title":"Biochemistry"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1016\/j.bmcl.2011.04.021","article-title":"Phosphodiesterase inhibitors. Part 1: Synthesis and structure-activity relationships of pyrazolopyridine-pyridazinone PDE inhibitors developed from ibudilast","volume":"21","author":"RW Allcock","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1016\/j.bmcl.2011.06.118","article-title":"Phosphodiesterase inhibitors. Part 2: design, synthesis, and structure-activity relationships of dual PDE3\/4-inhibitory pyrazolo[1,5-a]pyridines with anti-inflammatory and bronchodilatory activity","volume":"21","author":"K Ochiai","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.bmc.2012.01.033","article-title":"Phosphodiesterase inhibitors. Part 3: Design, synthesis and structure-activity relationships of dual PDE3\/4-inhibitory fused bicyclic heteroaromatic-dihydropyridazinones with anti-inflammatory and bronchodilatory activity","volume":"20","author":"K Ochiai","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1016\/j.bmcl.2012.07.088","article-title":"Phosphodiesterase inhibitors. Part 4: design, synthesis and structure-activity relationships of dual PDE3\/4-inhibitory fused bicyclic heteroaromatic-4,4-dimethylpyrazolones","volume":"22","author":"K Ochiai","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bmcl.2012.08.121","article-title":"Phosphodiesterase inhibitors. Part 5: hybrid PDE3\/4 inhibitors as dual bronchorelaxant\/anti-inflammatory agents for inhaled administration","volume":"23","author":"K Ochiai","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1021\/bi049868i","article-title":"Crystal Structure of Human Phosphodiesterase 3B: Atomic Basis for Substrate and Inhibitor Specificity","volume":"43","author":"G Scapin","year":"2004","journal-title":"Biochemistry"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1016\/j.bmcl.2003.08.056","article-title":"Benzyl vinylogous amide substituted aryldihydropyridazinones and aryldimethylpyrazolones as potent and selective PDE3B inhibitors","volume":"13","author":"SD Edmondson","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/jcc.20292","article-title":"Integrated Modeling Program, Applied Chemical Theory (IMPACT)","volume":"26","author":"JL Banks","year":"2005","journal-title":"J Comput Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins","volume":"12","author":"E Harder","year":"2016","journal-title":"J Chem Theory Comput"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Bowers KJ, Chow E, Xu H, Dror RO, Eastwood MP, Gregersen BA, et al. Scalable algorithms for molecular dynamics simulations on commodity clusters. Proceedings of the 2006 ACM\/IEEE conference on Supercomputing. Tampa, Florida: ACM; 2006. p. 84. <comment>doi: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/doi.org\/10.1145\/1188455.1188544\" xlink:type=\"simple\">10.1145\/1188455.1188544<\/ext-link><\/comment>","DOI":"10.1145\/1188455.1188544"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"W407","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"M Wiederstein","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"RA Laskowski","year":"1993","journal-title":"Journal of Applied Crystallography"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pK (a) prediction and protonation state generation for drug-like molecules","volume":"21","author":"JC Shelley","year":"2007","journal-title":"J Comput Aided Mol Des"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"RA Friesner","year":"2004","journal-title":"J Med Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"TA Halgren","year":"2004","journal-title":"J Med Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"64756","DOI":"10.1039\/C6RA12084A","article-title":"Computational study of the binding orientation and affinity of PPAR\u03b3 agonists: inclusion of ligand-induced fit by cross-docking","volume":"6","author":"C Mu\u00f1oz-Gutierrez","year":"2016","journal-title":"RSC Adv"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1021\/ci400696v","article-title":"Template CoMFA: The 3D-QSAR Grail?","volume":"54","author":"RD Cramer","year":"2014","journal-title":"J Chem Inf Model"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1021\/ja00226a005","article-title":"Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins","volume":"110","author":"RD Cramer","year":"1988","journal-title":"J Am Chem Soc"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1021\/jm00050a010","article-title":"Molecular Similarity Indices in a Comparative Analysis (CoMSIA) of Drug Molecules to Correlate and Predict Their Biological Activity","volume":"37","author":"G Klebe","year":"1994","journal-title":"J Med Chem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1021\/ja00214a001","article-title":"The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin","volume":"110","author":"WL Jorgensen","year":"1988","journal-title":"J Am Chem Soc"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1021\/ct900587b","article-title":"Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field","volume":"6","author":"D Shivakumar","year":"2010","journal-title":"J Chem Theory Comput"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1021\/jp980230o","article-title":"Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods","volume":"102","author":"AK Ghose","year":"1998","journal-title":"J Phys Chem A"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1093-3263(01)00123-1","article-title":"Beware of q2!","volume":"20","author":"A Golbraikh","year":"2002","journal-title":"J Mol Graph Model"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/qsar.200430909","article-title":"The Better Predictive Model: High q2 for the Training Set or Low Root Mean Square Error of Prediction for the Test Set?","volume":"24","author":"AO Aptula","year":"2005","journal-title":"QSAR Comb Sci"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0959-440X(97)80027-9","article-title":"Advances in comparative protein-structure modelling","volume":"7","author":"R S\u00e1nchez","year":"1997","journal-title":"Curr Opin Struct Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.str.2004.10.004","article-title":"Structural basis for the activity of drugs that inhibit phosphodiesterases","volume":"12","author":"GL Card","year":"2004","journal-title":"Structure"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmgm.2012.03.001","article-title":"Development of docking-based 3D-QSAR models for PPARgamma full agonists","volume":"36","author":"L Guasch","year":"2012","journal-title":"J Mol Graph Model"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e0161111","DOI":"10.1371\/journal.pone.0161111","article-title":"Flavonoids as CDK1 Inhibitors: Insights in Their Binding Orientations and Structure-Activity Relationship","volume":"11","author":"C Navarro-Retamal","year":"2016","journal-title":"PLoS One"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10822-014-9761-z","article-title":"Challenging the gold standard for 3D-QSAR: template CoMFA versus X-ray alignment","volume":"28","author":"B Wendt","year":"2014","journal-title":"J Comput Aided Mol Des"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1747-0285.2011.01186.x","article-title":"Binding studies and quantitative structure-activity relationship of 3-amino-1H-indazoles as inhibitors of GSK3\u03b2","volume":"78","author":"J Caballero","year":"2011","journal-title":"Chem Biol Drug Des"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0189213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T13:26:38Z","timestamp":1570454798000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0189213"}},"subtitle":[],"editor":[{"given":"Alessio","family":"Lodola","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,12,7]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0189213","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,7]]}}}